Evidence map›Paper›PMID 38555343›Full record

ArticleNPJ Parkinson's disease2024

Investigating the aspect of asymmetry in brain-first versus body-first Parkinson's disease.

S S Lövdal, G Carli, B Orso, M Biehl, D Arnaldi, P Mattioli, A Janzen, E Sittig, S Morbelli, J Booij and 3 more

Abstract read
In one paragraph

Article in NPJ Parkinson's disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Review
  3. An exploratoryEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  4. A novel rat model of body first subtype of Parkinson's disease.bioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. IRMA: Machine learning-based harmonization ofEuropean journal of nuclear medicine and molecular imaging · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

S S Lövdal *Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands. s.s.lovdal@rug.nl.ORCID http://orcid.org/0000-0002-8219-6590
G Carli *Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands.
B OrsoDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.ORCID http://orcid.org/0000-0001-9983-7940
M BiehlBernoulli Institute for Mathematics, Computer Science and Artificial Intelligence, University of Groningen, Groningen, Netherlands.ORCID http://orcid.org/0000-0001-5148-4568
D ArnaldiDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.ORCID http://orcid.org/0000-0001-6823-6069
P MattioliDepartment of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DINOGMI), University of Genoa, Genoa, Italy.
A JanzenDepartment of Neurology, Philipps-University Marburg, Marburg, Germany.
E SittigDepartment of Neurology, Philipps-University Marburg, Marburg, Germany.
S MorbelliDepartment of Health Sciences, University of Genoa, Genoa, Italy.
J BooijDepartment of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands.
W H OertelDepartment of Neurology, Philipps-University Marburg, Marburg, Germany.
K L LeendersDepartment of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, Netherlands.
S K MelesDepartment of Neurology, University Medical Center Groningen, Groningen, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons in the substantia nigra. Recent literature has proposed two subgroups of PD. The "body-first subtype" is associated with a prodrome of isolated REM-sleep Behavior Disorder (iRBD) and a relatively symmetric brain degeneration. The "brain-first subtype" is suggested to have a more asymmetric degeneration and a prodromal stage without RBD. This study aims to investigate the proposed difference in symmetry of the degeneration pattern in the presumed body and brain-first PD subtypes. We analyzed

Identifiers

PMID38555343
PMCPMC10981719

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.